Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Levofloxacin

tablet, 500 mg, once a day for ten days

DRUG

Amoxicillin

tablet, 1000 mg, once a day for ten days

DRUG

Lansoprazole

capsule, 30 mg, twice a day for ten days

Trial Locations (1)

38039

Erciyes University School of Medicine Hospital, Department of Internal Medicine and Gastroenterology, Kayseri

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

TNC Ilac Arastirma Gelistirme Danismanlik San. ve Tic. Ltd. Sti.

OTHER

collaborator

TC Erciyes University

OTHER

lead

Deva Holding A.S.

INDUSTRY